1cP-LSD: Difference between revisions

>LockPicker
m citations
>LockPicker
m grammar
Line 4: Line 4:
{{SummarySheet}}
{{SummarySheet}}
{{SubstanceBox/1cP-LSD}}
{{SubstanceBox/1cP-LSD}}
'''1-Cyclopropionyl-''d''-lysergic acid diethylamide''' (also known as '''1cP-LSD''') is a novel semisynthetic [[Psychoactive class::psychedelic]] substance of the [[Chemical class::lysergamide]] class.
'''1-Cyclopropionyl-''d''-lysergic acid diethylamide''' (known as '''1cP-LSD''') is a novel semisynthetic [[Psychoactive class::psychedelic]] substance of the [[Chemical class::lysergamide]] class. It induces its psychedelic effects by acting on [[serotonin]] [[receptors]] in the brain.<ref name="Brandt2020">{{cite journal|title=Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1‐cyclopropanoyl‐d‐lysergic acid diethylamide (1CP‐LSD)|first1=Simon D.|last1=Brandt|first2=Pierce V.|last2=Kavanagh|first3=Folker|last3=Westphal|first4=Alexander|last4=Stratford|first5=Anna U.|last5=Odland|first6=Adam K.|last6=Klein|first7=Geraldine|last7=Dowling|first8=Nicola M.|last8=Dempster|first9=Jason|last9=Wallach|first10=Torsten|last10=Passie|first11=Adam L.|last11=Halberstadt|date=March 16, 2020|doi=10.1002/dta.2789|volume=12|issue=6|journal=Drug Testing and Analysis|pages=812-826|eissn=1942-7611|issn=1942-7603|oclc=231680670}}</ref> 1cP-LSD is closely related to [[1P-LSD]] and [[LSD]]. It is reported to produce similar to identical effects.
1cP-LSD is closely related to [[1P-LSD]] and [[LSD]]. It is reported to produce similar to identical effects.
Little is known about the pharmacology of 1cP-LSD, it produces its psychedelic effects by acting on [[serotonin]] [[receptors]] in the brain.<ref name="Brandt2020">{{cite journal|title=Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1‐cyclopropanoyl‐d‐lysergic acid diethylamide (1CP‐LSD)|first1=Simon D.|last1=Brandt|first2=Pierce V.|last2=Kavanagh|first3=Folker|last3=Westphal|first4=Alexander|last4=Stratford|first5=Anna U.|last5=Odland|first6=Adam K.|last6=Klein|first7=Geraldine|last7=Dowling|first8=Nicola M.|last8=Dempster|first9=Jason|last9=Wallach|first10=Torsten|last10=Passie|first11=Adam L.|last11=Halberstadt|date=March 16, 2020|doi=10.1002/dta.2789|volume=12|issue=6|journal=Drug Testing and Analysis|pages=812-826|eissn=1942-7611|issn=1942-7603|oclc=231680670}}</ref>


Incubation of 1CP‐LSD with human serum led to the formation of LSD, indicating that it may act as a [[prodrug]] for LSD.<ref name="Brandt2020"></ref>
Little is known about the pharmacology. Incubation of 1CP‐LSD with human serum led to the formation of LSD, indicating that it may act as a [[prodrug]] for LSD.<ref name="Brandt2020"></ref>
Characteristic effects include [[geometry|geometric visual hallucinations]], [[time distortion]], [[introspection|enhanced introspection]], and [[ego loss]].  
Characteristic effects include [[geometry|geometric visual hallucinations]], [[time distortion]], [[introspection|enhanced introspection]], and [[ego loss]].  


1cP-LSD appeared on the online [[research chemical]] market as a new legal alternative to LSD when 1P-LSD was prohibited in germany.
1cP-LSD appeared on the online [[research chemical]] market as a new legal alternative to LSD when 1P-LSD was prohibited in Germany.
 
It is highly advised to use [[harm reduction practices]] if using this substance.
It is highly advised to use [[harm reduction practices]] if using this substance.